Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate

Kidney International

Volumn 80, Issue 2, 2011, Pages 181-189

  Brodsky, Sergey V ^a   Nadasdy, Tibor ^a   Rovin, Brad H ^a   Satoskar, Anjali A ^a   Nadasdy, Gyongyi M ^a   Wu, Haifeng M ^a   Bhatt, Udayan Y ^a   Hebert, Lee A ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

acute kidney injury; mortality; warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; CLOPIDOGREL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; ERYTHROPOIETIN; HEPARIN; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MINOXIDIL; NONSTEROID ANTIINFLAMMATORY AGENT; SALBUTAMOL; TICLOPIDINE; WARFARIN;

ADULT; AGE; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG INDUCED DISEASE; DRUG USE; FEMALE; HEMATURIA; HUMAN; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE; WARFARIN RELATED NEPHROPATHY;

EID: 79959774679     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.44     Document Type: Article

References (16)

1. Brodsky SV, Satoskar A, Chen J et al. Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases. Am J Kidney Dis 2009; 54: 1121-1126.
2. Brodsky SV, Collins M, Park E et al. Warfarin therapy that results in an international normalization ratio above the therapeutic range is associated with accelerated progression of chronic kidney disease. Nephron Clin Pract 2010; 115: c142-c146.
3. Mehta RL, Kellum JA, Shah SV et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11: R31.
4. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
5. Kabir A, Nadasdy T, Nadasdy G et al. An unusual cause of gross hematuria and transient ARF in an SLE patient with warfarin coagulopathy. Am J Kidney Dis 2004; 43: 757-760. (Pubitemid 38401893)
6. Abt AB, Carroll LE, Mohler JH. Thin basement membrane disease and acute renal failure secondary to gross hematuria and tubular necrosis. Am J Kidney Dis 2000; 35: 533-536.
7. Wysowski DK, Nourjah P, Swartz L. Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. Arch Intern Med 2007; 167: 1414-1419. (Pubitemid 47052441)
8. Chan KE, Lazarus JM, Thadhani R et al. Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients. J Am Soc Nephrol 2009; 20: 872-881.
9. Chan KE, Lazarus JM, Thadhani R et al. Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. J Am Soc Nephrol 2009; 20: 2223-2233.
10. Moll S, Huffman J. Cholesterol emboli associated with warfarin treatment. Am J Hematol 2004; 77: 194-195. (Pubitemid 39281868)
11. Kapoor KG, Bekaii-Saab T. Warfarin-induced allergic interstitial nephritis and leucocytoclastic vasculitis. Intern Med J 2008; 38: 281-283. (Pubitemid 351465458)
12. Yanagita M. Gas6, warfarin, and kidney diseases. Clin Exp Nephrol 2004; 8: 304-309. (Pubitemid 40941105)
13. Limdi NA, Beasley TM, Baird MF et al. Kidney function influences warfarin responsiveness and hemorrhagic complications. J Am Soc Nephrol 2009; 20: 912-921.
14. Eknoyan G, Levin NW, Eschbach JW et al. Continuous quality improvement: DOQI becomes K/DOQI and is updated. National Kidney Foundation's Dialysis Outcomes Quality Initiative. Am J Kidney Dis 2001; 37: 179-194.
15. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979; 6: 65-70.
16. Moeschberger ML, Klein JP. Survival Analysis: Techniques for Censored and Truncated Data, 2nd edn. Springer: New York, NY, 2005.